122 related articles for article (PubMed ID: 8075308)
1. Annexin V as a probe of the contribution of anionic phospholipids to the procoagulant activity of tumour cell surfaces.
Sugimura M; Donato R; Kakkar VV; Scully MF
Blood Coagul Fibrinolysis; 1994 Jun; 5(3):365-73. PubMed ID: 8075308
[TBL] [Abstract][Full Text] [Related]
2. Measurement of membrane phospholipid asymmetry in normal and sickle-cell erythrocytes by means of annexin V binding.
Tait JF; Gibson D
J Lab Clin Med; 1994 May; 123(5):741-8. PubMed ID: 8195679
[TBL] [Abstract][Full Text] [Related]
3. Binding of annexin V to a human ovarian carcinoma cell line (OC-2008). Contrasting effects on cell surface factor VIIa/tissue factor activity and prothrombinase activity.
Rao LV; Tait JF; Hoang AD
Thromb Res; 1992 Sep; 67(5):517-31. PubMed ID: 1448786
[TBL] [Abstract][Full Text] [Related]
4. Increased exposure of anionic phospholipids on the surface of tumor blood vessels.
Ran S; Downes A; Thorpe PE
Cancer Res; 2002 Nov; 62(21):6132-40. PubMed ID: 12414638
[TBL] [Abstract][Full Text] [Related]
5. The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein Ib.
Connor DE; Exner T; Ma DD; Joseph JE
Thromb Haemost; 2010 May; 103(5):1044-52. PubMed ID: 20390225
[TBL] [Abstract][Full Text] [Related]
6. Ultrastructural detection of surface exposed phosphatidylserine on activated blood platelets.
Stuart MC; Bevers EM; Comfurius P; Zwaal RF; Reutelingsperger CP; Frederik PM
Thromb Haemost; 1995 Oct; 74(4):1145-51. PubMed ID: 8560427
[TBL] [Abstract][Full Text] [Related]
7. Merocyanine 540 as a fluorescent probe of altered membrane phospholipid asymmetry in activated whole blood platelets.
Watala C; Waczulikova I; Wieclawska B; Rozalski M; Gresner P; Gwoździński K; Mateasik A; Sikurova L
Cytometry; 2002 Nov; 49(3):119-33. PubMed ID: 12442312
[TBL] [Abstract][Full Text] [Related]
8. Annexin V inhibition of factor IXa-catalyzed factor X activation on human platelets and on negatively-charged phospholipid vesicles.
London F; Ahmad SS; Walsh PN
Biochemistry; 1996 Dec; 35(51):16886-97. PubMed ID: 8988028
[TBL] [Abstract][Full Text] [Related]
9. Binding of annexin V to bilayers with various phospholipid compositions using glass beads in a flow cytometer.
Stuart MC; Reutelingsperger CP; Frederik PM
Cytometry; 1998 Dec; 33(4):414-9. PubMed ID: 9845435
[TBL] [Abstract][Full Text] [Related]
10. Lactadherin binding and phosphatidylserine expression on cell surface-comparison with annexin A5.
Dasgupta SK; Guchhait P; Thiagarajan P
Transl Res; 2006 Jul; 148(1):19-25. PubMed ID: 16887494
[TBL] [Abstract][Full Text] [Related]
11. Effects of lanthanide ions on the binding ability of annexin V to phospholipid vesicle.
Funakoshi T; Furushima K; Mizokami H; Kojima S
Biochem Mol Biol Int; 1996 Apr; 38(5):965-72. PubMed ID: 9132165
[TBL] [Abstract][Full Text] [Related]
12. Human annexin V binds to sulfatide: contribution to regulation of blood coagulation.
Ida M; Satoh A; Matsumoto I; Kojima-Aikawa K
J Biochem; 2004 May; 135(5):583-8. PubMed ID: 15173196
[TBL] [Abstract][Full Text] [Related]
13. Discrepancy between tissue factor activity and tissue factor expression in endotoxin-induced monocytes is associated with apoptosis and necrosis.
Henriksson CE; Klingenberg O; Ovstebø R; Joø GB; Westvik AB; Kierulf P
Thromb Haemost; 2005 Dec; 94(6):1236-44. PubMed ID: 16411400
[TBL] [Abstract][Full Text] [Related]
14. Procoagulant activity of T lymphoblastoid cells due to exposure of negatively charged phospholipid.
Barrowcliffe TW; Fábregas P; Jardi M; Cancelas J; Rabaneda M; Felez J
Thromb Haemost; 2002 Mar; 87(3):442-9. PubMed ID: 11916077
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous tissue factor expression and phosphatidylserine exposure account for the highly procoagulant pattern of melanoma cell lines.
Kirszberg C; Lima LG; Da Silva de Oliveira A; Pickering W; Gray E; Barrowcliffe TW; Rumjanek VM; Monteiro RQ
Melanoma Res; 2009 Oct; 19(5):301-8. PubMed ID: 19550359
[TBL] [Abstract][Full Text] [Related]
16. Antiphospholipid antibodies accelerate plasma coagulation by inhibiting annexin-V binding to phospholipids: a "lupus procoagulant" phenomenon.
Rand JH; Wu XX; Andree HA; Ross JB; Rusinova E; Gascon-Lema MG; Calandri C; Harpel PC
Blood; 1998 Sep; 92(5):1652-60. PubMed ID: 9716593
[TBL] [Abstract][Full Text] [Related]
17. Prolonged expression of procoagulant activity of human platelets degranulated by thrombin.
Kinlough-Rathbone RL; Perry DW
Thromb Haemost; 1995 Sep; 74(3):958-61. PubMed ID: 8571329
[TBL] [Abstract][Full Text] [Related]
18. Lactadherin and procoagulant activities of red blood cells in cyclosporine induced thrombosis.
Zheng YN; Yu HJ; Hou JX; Lu CF; Zhou J
Chin Med J (Engl); 2009 Jul; 122(14):1674-80. PubMed ID: 19719970
[TBL] [Abstract][Full Text] [Related]
19. A novel assay to measure loss of plasma membrane asymmetry during apoptosis of adherent cells in culture.
van Engeland M; Ramaekers FC; Schutte B; Reutelingsperger CP
Cytometry; 1996 Jun; 24(2):131-9. PubMed ID: 8725662
[TBL] [Abstract][Full Text] [Related]
20. Lactadherin detects early phosphatidylserine exposure on immortalized leukemia cells undergoing programmed cell death.
Shi J; Shi Y; Waehrens LN; Rasmussen JT; Heegaard CW; Gilbert GE
Cytometry A; 2006 Dec; 69(12):1193-201. PubMed ID: 17123296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
